Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research into antibiotic-resistant E. coli

Estimates reveal effect of chicken production on humans

Research has revealed that approximately 280 people die every year in the UK as a result of antibiotic-resistant E. coli, acquired from chicken.

The study, carried out by an international team of scientists, looked at the effect of using third-generation cephalosporin – a class of antibiotics – in chicken production.

It is known that the method is causing a rise the number of E. coli cases that are resistant to antibiotics, which is called extended-spectrum beta-lactamase (ESBL) E coli.

The team used Dutch genetic fingerprinting to find a reliable estimate of the number of human blood poisoning infections and deaths caused by ESBL E. coli that have come about as a result of consuming chicken.

They found that chicken production is, according to their analysis, responsible for 1,580 cases of ESBL E. coli blood poisoning every year in the UK.

Furthermore, it was revealed that
each year poultry-associated ESBL E. coli causes an additional 12,500 days in UK hospitals for "last-resort" antibiotic treatment.

"This is the first detailed estimate to emerge of the human-health consequences from the use of antibiotics in European agriculture," said Richard Young, policy adviser at the Soil Association.

"It indicated that large numbers of people die of resistant infections due to the over-reliance on antibiotics in intensive livestock farming."

He added that there are also major additional costs to the NHS from treating patients – even when they survive an ESBL E. coli infection.

Related News
Concerns over resistant E.coli superbugs
Antibiotics a key issue at G8

 

Become a member or log in to add this story to your CPD history

Submissions open for BSAVA Clinical Research Abstracts 2026

News Story 1
 The BSAVA has opened submissions for the BSAVA Clinical Research Abstracts 2026.

It is an opportunity for applicants to present new research on any veterinary subject, such as the preliminary results of a study, discussion of a new technique or a description of an interesting case.

They must be based on high-quality clinical research conducted in industry, practice or academia, and summarised in 250 words.

Applications are welcome from vets, vet nurses, practice managers, and students.

Submissions are open until 6 March 2026. 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk